Results for: Quiz 1z0-076 - Oracle Database 19c: Data Guard Administration Marvelous Reliable Exam Sample πŸ”‘ Download β–· 1z0-076 ◁ for free by simply searching on β€œ www.pdfvce.com ” πŸ˜™1z0-076 Valid Test Tips

Depression and cardiovascular disease: SADHART results

…The SADHART (Sertraline Antidepressant Heart Attack Randomized Trial) study was a placebo-controlled trial of the SSRI sertraline in 369 patients with acute coronary syndrome who met diagnostic criteria for major depression (Glassman et al. Arch Gen Psychiatry 2009; 66: 102-1029). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…

Chronic cerebrospinal venous insufficiency (CCSVI)

View commentary by Daniel Selchen, MD Following news reports last fall of a possible cure for MS, clinicians and MS Societies worldwide have been inundated with inquiries about the new procedure. Its originator, Dr. Paulo Zamboni of Ferrara, Italy, has reported that a condition that he calls chronic cerebrospinal venous insufficiency (CCSVI) is the underlying problem in multiple sclerosis. Subscribe to read more It takes 30 seconds or login using…

CSF biomarkers of AD in MCI patients

…linically useful biomarkers to identify MCI patients at risk of developing AlzheimerΒ’s disease has proved elusive with conflicting results reported by different centres. In Sweden, a large multicentre study has investigated the accuracy of CSF beta-amyloid(1-42), total tau protein (T-tau), and tau phosphorylated at position threonine 181 (P-tau) (Mattsson et al. JAMA 2009; 302: 385-393). Subscribe to read more It takes 30 seconds or login using yo…

Consensus statement: aripiprazole for acute mania

for acute mania (Aitchison et al. J Psychopharmacol 2009; 23: 231-240). Unlike other atypical antipsychotic agents (clozapine, risperidone, olanzapine, quetiapine, ziprasidone), aripiprazole acts as a partial agonist at the dopamine D2 and serotonin 5HT-1A and 5HT-2C receptors, and as a 5HT-2A antagonist (for a recent review see Pae CU. Expert Opin Drug Saf 2009; 8: 373-386). Subscribe to read more It takes 30 seconds or login using your email ad…

L-dopa-induced dyskinesias: 24-month data

…ORENCE, ITALY, SEPTEMBER 12-15, 2009 – One-quarter of PD patients develop L-dopa-induced dyskinesias, according to the interim analysis of patients in the COPARK (Cohorte nationale de patients atteints de maladie de Parkinson)/PARKMIP (Midi-Pyrénées region) trial (Perez-Lloret et al. EFNS 2009). L-dopa-induced dyskinesia was defined as UPDRS IV (item 32) ≥ 1. Subscribe to read more It takes 30 seconds or login using your email address Please enter…